White matter changes in HIV-1 infected brains: A combined gross anatomical and ultrastructural morphometric investigation of the corpus callosum

Clinical Neurology and Neurosurgery

Volumn 111, Issue 5, 2009, Pages 422-429

  Wohlschlaeger, J ^a,b   Wenger, E ^c   Mehraein, P ^b   Weis, S ^b,d  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^d KEPLER UNIVERSITY HOSPITAL   (Austria)

Author keywords

Corpus callosum; Electronmicroscopy; HIV 1 leucoencephalopathy; Morphometry; Myelin sheaths; Nerve fibers; White matter

Indexed keywords

ADULT; ARTICLE; BRAIN DAMAGE; BRAIN INFECTION; COGNITION; CONTROLLED STUDY; CORPUS CALLOSUM; ELECTRON MICROSCOPY; FEMALE; HISTOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN TISSUE; LEUKOENCEPHALOPATHY; MALE; MORPHOMETRICS; MOTOR PERFORMANCE; MYELIN SHEATH; NERVE FIBER; NERVE FIBER DEGENERATION; OCCIPITAL CORTEX; WHITE MATTER;

ADULT; ASTROCYTES; AXONS; BRAIN; CELL COUNT; CORPUS CALLOSUM; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; MIDDLE AGED; MYELIN SHEATH; NERVE FIBERS;

EID: 67349250145     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2008.12.006     Document Type: Article

References (71)

1. Navia B.A., Jordan B.D., and Price R.W. The AIDS dementia complex. I. Clinical features. Ann Neurol 19 (1986) 517-524
2. McArthur J.C., Haughey N., Gartner S., Conant K., Pardo C., Nath A., et al. Human immunodeficiency virus-associated dementia: an evolving disease. J Neurovirol 9 (2003) 205-221
3. McArthur J.C. HIV dementia: an evolving disease. J Neuroimmunol 157 (2004) 3-10
4. Budka H. Human immunodeficiency virus (HIV)-induced disease of the central nervous system: pathology and implications for pathogenesis. Acta Neuropathol 77 (1989) 225-236
5. Weis S., Haug H., and Budka H. Neuronal damage in the cerebral cortex of AIDS brains: a morphometric study. Acta Neuropathol 85 (1993) 185-189
6. Buttner A., Mehraein P., and Weis S. Vascular changes in the cerebral cortex in HIV-1 infection. II. An immunohistochemical and lectinhistochemical investigation. Acta Neuropathol 92 (1996) 35-41
7. Gray F., Chretien F., Vallat-Decouvelaere A.V., and Scaravilli F. The changing pattern of HIV neuropathology in the HAART era. J Neuropathol Exp Neurol 62 (2003) 429-440
8. Gray F., Bazille C., dle-Biassette H., Mikol J., Moulignier A., and Scaravilli F. Central nervous system immune reconstitution disease in acquired immunodeficiency syndrome patients receiving highly active antiretroviral treatment. J Neurovirol 11 Suppl. 3 (2005) 16-22
9. Sacktor N. The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. J Neurovirol 8 Suppl. 2 (2002) 115-121
10. Cherner M., Masliah E., Ellis R.J., Marcotte T.D., Moore D.J., Grant I., et al. Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis. Neurology 59 (2002) 1563-1567
11. Diesing T.S., Swindells S., Gelbard H., and Gendelman H.E. HIV-1-associated dementia: a basic science and clinical perspective. AIDS Read 12 (2002) 358-368
12. Langford T.D., Letendre S.L., Larrea G.J., and Masliah E. Changing patterns in the neuropathogenesis of HIV during the HAART era. Brain Pathol 13 (2003) 195-210
13. Navia B.A., Cho E.S., Petito C.K., and Price R.W. The AIDS dementia complex. II. Neuropathology. Ann Neurol 19 (1986) 525-535
14. Ketzler S., Weis S., Haug H., and Budka H. Loss of neurons in the frontal cortex in AIDS brains. Acta Neuropathol 80 (1990) 92-94
15. Pfefferbaum A., Rosenbloom M.J., Adalsteinsson E., and Sullivan E.V. Diffusion tensor imaging with quantitative fibre tracking in HIV infection and alcoholism comorbidity: synergistic white matter damage. Brain 130 (2007) 48-64
16. Stebbins G.T., Smith C.A., Bartt R.E., Kessler H.A., Adeyemi O.M., Martin E., et al. HIV-associated alterations in normal-appearing white matter: a voxel-wise diffusion tensor imaging study. J Acquir Immune Defic Syndr 46 (2007) 564-573
17. Bancroft J.D. Manual of histological techniques and their diagnostic application (1994), Churchill Livingstone
18. Itoh K., Mehraein P., and Weis S. Astroglial reaction patterns in HIV-1 infected brains. Neuropathology 16 (2001) 225-230
19. Weis S., Kretschmar H.A., Böhnel W., and Mehraein P. Topography of gp41-positive cells and microglia/macrophages in AIDS brains. Clin Neuropathol 11 (2001) 92-100
20. Weis S., Neuhaus B., and Mehraein P. Activation of microglia in HIV-1 infected brains is not dependent on the presence of HIV-1 antigens. Neuroreport 5 (1994) 1514-1516
21. Gundersen H.J.G. Notes on the estimation of the numerical density of arbitrary profiles: the edge effect. Acta Derm Venereol 57 (1977) 173-176
22. Tomasch J. Size, distribution, and number of fibres in the human corpus callosum. Anat Rec 119 (1954) 119-135
23. Aboitiz F., Scheibel A.B., Fisher R.S., and Zaidel E. Fiber composition of the human corpus callosum. Brain Res 598 (1992) 143-153
24. Weis S., Jellinger K., and Wenger E. Morphometry of the corpus callosum in normal aging and Alzheimer's disease. J Neural Transm Suppl 33 (1991) 35-38
25. Biegon A., Eberling J.L., Richardson B.C., Roos M.S., Wong S.T., Reed B.R., et al. Human corpus callosum in aging and Alzheimer's disease: a magnetic resonance imaging study. Neurobiol Aging 15 (1994) 393-397
26. Janowsky J.S., Kaye J.A., and Carper R.A. Atrophy of the corpus callosum in Alzheimer's disease versus healthy aging. J Am Geriatr Soc 44 (1996) 798-803
27. Black S.E., Moffat S.D., Yu D.C., Parker J., Stanchev P., and Bronskill M. Callosal atrophy correlates with temporal lobe volume and mental status in Alzheimer's disease. Can J Neurol Sci 27 (2000) 204-209
28. Hallam B.J., Brown W.S., Ross C., Buckwalter J.G., Bigler E.D., Tschanz J.T., et al. Regional atrophy of the corpus callosum in dementia. J Int Neuropsychol Soc 14 (2008) 414-423
29. Olsen W.L., Longo F.M., Mills C.M., and Norman D. White matter disease in AIDS: findings at MR imaging. Radiology 169 (1988) 445-448
30. McArthur J.C., Kumar A.J., Johnson D.W., Selnes O.A., Becker J.T., Herman C., et al. Incidental white matter hyperintensities on magnetic resonance imaging in HIV-1 infection. Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr 3 (1990) 252-259
31. Bornstein R.A., Chakeres D., Brogan M., Nasrallah H.A., Fass R.J., Para M., et al. Magnetic resonance imaging of white matter lesions in HIV infection. J Neuropsychiatry Clin Neurosci 4 (1992) 174-178
32. Bornstein R.A., Nasrallah H.A., Para M.F., Whitacre C.C., Rosenberger P., and Fass R.J. Neuropsychological performance in symptomatic and asymptomatic HIV infection. AIDS 7 (1993) 519-524
33. Wilkinson I.D., Miller R.F., Hall-Craggs M.A., Paley M.N., and Harrison M.J. Short echo-time proton magnetic resonance spectroscopy in regions of severe HIV-related diffuse white matter abnormality on MRI. J NeuroAIDS 2 (1998) 55-67
34. Pomara N., Crandall D.T., Choi S.J., Johnson G., and Lim K.O. White matter abnormalities in HIV 1 infection: a diffusion tensor imaging study. Psychiatry Res 106 (2001) 15-24
35. Filippi C.G., Ulug A.M., Ryan E., Ferrando S.J., and van G.W. Diffusion tensor imaging of patients with HIV and normal-appearing white matter on MR images of the brain. AJNR Am J Neuroradiol 22 (2001) 277-283
36. Cloak C.C., Chang L., and Ernst T. Increased frontal white matter diffusion is associated with glial metabolites and psychomotor slowing in HIV. J Neuroimmunol 157 (2004) 147-152
37. Anders K.H., Guerra W.F., Tomiyasu U., Verity M.A., and Vinters H.V. The neuropathology of AIDS. UCLA experience and review. Am J Pathol 124 (1986) 537-558
38. Price R.W., Brew B., Sidtis J., Rosenblum M., Scheck A.C., and Cleary P. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 239 (1988) 586-592
39. Budka H., Wiley C.A., Kleihues P., Artigas J., Asbury A.K., Cho E.S., et al. HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol 1 (1991) 143-152
40. Raja F., Sherriff F.E., Morris C.S., Bridges L.R., and Esiri M.M. Cerebral white matter damage in HIV infection demonstrated using beta-amyloid precursor protein immunoreactivity. Acta Neuropathol 93 (1997) 184-189
41. Parmantier E., Monge M., Yagello M., Cabon F., Demerens C., Gluckman J.C., et al. HIV-1 envelope glycoprotein gp120 does not bind to galactosylceramide-expressing rat oligodendrocytes. Virology 206 (1995) 1084-1091
42. Sidtis J.J., and Price R.W. Early HIV-1 infection and the AIDS dementia complex. Neurology 40 (1990) 323-326
43. Esiri M.M., Morris C.S., and Millard P.R. Fate of oligodendrocytes in HIV-1 infection. AIDS 5 (1991) 1081-1088
44. Peavy G., Jacobs D., Salmon D.P., Butters N., Delis D.C., Taylor M., et al. Verbal memory performance of patients with human immunodeficiency virus infection: evidence of subcortical dysfunction. The HNRC Group. J Clin Exp Neuropsychol 16 (1994) 508-523
45. Weis S., Kimbacher M., Wenger E., and Neuhold A. Morphometric analysis of the corpus callosum using MR: correlation of measurements with aging in healthy individuals. AJNR Am J Neuroradiol 14 (1993) 637-645
46. Everall I.P., Luthert P.J., and Lantos P.L. Neuronal loss in the frontal cortex in HIV infection. Lancet 337 (1991) 1119-1121
47. Wiley C.A., Masliah E., Morey M., Lemere C., DeTeresa R., Grafe M., et al. Neocortical damage during HIV infection. Ann Neurol 29 (1991) 651-657
48. Masliah E., Ge N., Morey M., DeTeresa R., Terry R.D., and Wiley C.A. Cortical dendritic pathology in human immunodeficiency virus encephalitis. Lab Invest 66 (1992) 285-291
49. Weis S., Haug H., and Budka H. Astroglial changes in the cerebral cortex of AIDS brains: a morphometric and immunohistochemical investigation. Neuropathol Appl Neurobiol 19 (1993) 329-335
50. Giangaspero F., and Foschini M.P. Diffuse axonal swellings in a case of acquired immunodeficiency syndrome. Arch Pathol Lab Med 112 (1988) 1259-1262
51. Esiri M.M., and Morris C.S. Cellular basis of HIV infection of the CNS and the AIDS dementia complex: oligodendrocyte. J NeuroAIDS 1 (1996) 133-160
52. Pumarola-Sune T., Navia B.A., Cordon-Cardo C., Cho E.S., and Price R.W. HIV antigen in the brains of patients with the AIDS dementia complex. Ann Neurol 21 (1987) 490-496
53. Albright A.V., Strizki J., Harouse J.M., Lavi E., O'Connor M., and Gonzalez-Scarano F. HIV-1 infection of cultured human adult oligodendrocytes. Virology 217 (1996) 211-219
54. Kandel, et al. Principles of Neural Science. 3rd ed. (1991), Elsevier
55. Radja F., Kay D.G., Albrecht S., and Jolicoeur P. Oligodendrocyte-specific expression of human immunodeficiency virus type 1 Nef in transgenic mice leads to vacuolar myelopathy and alters oligodendrocyte phenotype in vitro. J Virol 77 (2003) 11745-11753
56. Kimura-Kuroda J., Nagashima K., and Yasui K. Inhibition of myelin formation by HIV-1 gp120 in rat cerebral cortex culture. Arch Virol 137 (1994) 81-99
57. Bernardo A., Agresti C., and Levi G. HIV-gp120 affects the functional activity of oligodendrocytes and their susceptibility to complement. J Neurosci Res 50 (1997) 946-957
58. Power C., Kong P.A., Crawford T.O., Wesselingh S., Glass J.D., McArthur J.C., et al. Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier. Ann Neurol 34 (1993) 339-350
59. Smith T.W., DeGirolami U., Henin D., Bolgert F., and Hauw J.J. Human immunodeficiency virus (HIV) leukoencephalopathy and the microcirculation. J Neuropathol Exp Neurol 49 (1990) 357-370
60. Gisslen M., Fredman P., Norkrans G., and Hagberg L. Elevated cerebrospinal fluid sulfatide concentrations as a sign of increased metabolic turnover of myelin in HIV type I infection. AIDS Res Hum Retroviruses 12 (1996) 149-155
61. Tyor W.R., Glass J.D., Griffin J.W., Becker P.S., McArthur J.C., Bezman L., et al. Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann Neurol 31 (1992) 349-360
62. Stanley L.C., Mrak R.E., Woody R.C., Perrot L.J., Zhang S., Marshak D.R., et al. Glial cytokines as neuropathogenic factors in HIV infection: pathogenic similarities to Alzheimer's disease. J Neuropathol Exp Neurol 53 (1994) 231-238
63. Pulliam L., Herndier B.G., Tang N.M., and McGrath M.S. Human immunodeficiency virus-infected macrophages produce soluble factors that cause histological and neurochemical alterations in cultured human brains. J Clin Invest 87 (1991) 503-512
64. Giulian D., Vaca K., and Noonan C.A. Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science 250 (1990) 1593-1596
65. Merrill J.E., Koyanagi Y., Zack J., Thomas L., Martin F., and Chen I.S. Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus type 1. J Virol 66 (1992) 2217-2225
66. Itoh K., Mehraein P., and Weis S. Astroglial reaction pattern in HIV-1 infected brains. Neuropathology 16 (1996) 225-230
67. Genis P., Jett M., Bernton E.W., Boyle T., Gelbard H.A., Dzenko K., et al. Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J Exp Med 176 (1992) 1703-1718
68. Robbins D.S., Shirazi Y., Drysdale B.E., Lieberman A., Shin H.S., and Shin M.L. Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes. J Immunol 139 (1987) 2593-2597
69. Selmaj K.W., and Raine C.S. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 23 (1988) 339-346
70. Vitkovic L., Kalebic T., and Fauci A.S. Astrocyte-conditioned medium stimulates HIV-1 expression in a chronically infected promonocyte clone. J Neuroimmunol 30 (1990) 153-160
71. Tornatore C., Nath A., Amemiya K., and Major E.O. Persistent human immunodeficiency virus type 1 infection in human fetal glial cells reactivated by T-cell factor(s) or by the cytokines tumor necrosis factor alpha and interleukin-1 beta. J Virol 65 (1991) 6094-6100